Evidence map›Paper›PMID 27754415›Full record

ArticleInternational journal of molecular sciences2016

Effect of Genetic Polymorphisms and Long-Term Tobacco Exposure on the Risk of Breast Cancer.

Zoraida Verde, Catalina Santiago, Luis Miguel Chicharro, Luis Reinoso-Barbero, Alejandro Tejerina, Fernando Bandrés, Félix Gómez-Gallego

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Association of CytochromeFrontiers in public health · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zoraida VerdeDepartment of Biomedical Sciences, European University, Madrid 28670, Spain. zoraida.verde@universidadeuropea.es.
Catalina SantiagoSchool of Doctoral Studies & Research, European University, Madrid 28670, Spain. catalina.santiago@universidadeuropea.es.
Luis Miguel ChicharroCátedra Complutense Diagnostic and Innovation, Universidad Complutense, Madrid 28040, Spain. luismi.chicharro@gmail.com.
Luis Reinoso-BarberoDepartment of Biomedical Sciences, European University, Madrid 28670, Spain. luis.reinoso@universidadeuropea.es.
Alejandro TejerinaCentro de Patología de la Mama-Fundación Tejerina, Madrid 28003, Spain. alejandro.tejerina@fjd.es.
Fernando BandrésCátedra Complutense Diagnostic and Innovation, Universidad Complutense, Madrid 28040, Spain. fbandres@med.ucm.es.
Félix Gómez-GallegoSchool of Doctoral Studies & Research, European University, Madrid 28670, Spain. felix.gomez@universidadeuropea.es.
Universidad Europea de Madrid · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTobacco smoke contains many potentially harmful compounds that may act differently and at different stages in breast cancer development. The focus of this work was to assess the possible role of cigarette smoking (status, dose, duration or age at initiation) and polymorphisms in genes coding for enzymes involved in tobacco carcinogen metabolism (

methodsWe designed a case control study with 297 patients, 217 histologically verified breast cancers (141 smokers and 76 non-smokers) and 80 healthy smokers in a cohort of Spanish women.

resultsWe found an association between smoking status and early age at diagnosis of breast cancer. Among smokers, invasive carcinoma subtype incidence increased with intensity and duration of smoking (all

conclusionsOur results support the main effect of CYP1A1 in estrogenic metabolism rather than in tobacco carcinogen activation in breast cancer patients and also confirmed the hypothesis that

Indexed as

Polymorphism, GeneticAdultAgedBreastBreast NeoplasmsCase-Control StudiesCytochrome P-450 CYP1A1Cytochrome P-450 CYP2A6DNA-(Apurinic or Apyrimidinic Site) LyaseDNA-Binding ProteinsFemaleGenetic Predisposition to DiseaseHumansMiddle AgedSmokingXeroderma Pigmentosum Group D ProteinAPEX1 protein, humanCYP1A1 protein, humanCYP2A6 protein, humanCytochrome P-450 CYP1A1Cytochrome P-450 CYP2A6DNA-(Apurinic or Apyrimidinic Site) LyaseDNA-Binding ProteinsERCC2 protein, humanXeroderma Pigmentosum Group D ProteinX-ray Repair Cross Complementing Protein 1X-ray repair cross complementing protein 3XRCC1 protein, humanbreast cancerCYP1ADNA repair geneslong-term smoking

Identifiers

PMID27754415
PMCPMC5085757
OpenAlexW2530136702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.